Antibiotic DE-3936, a polyether antibiotic identical with lonomycin. Taxonomy, fermentation, isolation and characterization
Related Experiment Videos
Abstract:
Antibiotic DE-3936 was isolated from the fermentation broth of a streptomycete No. 9735-1, which is identified as a strain of Streptomyces hygroscopicus. The antibiotic is a hydrophobic compound having the molecular formula of of C44H75O14Na and is active against Gram-positive bacteria, mycobacteria, mycoplasma and protozoa, especially coccidia. Its chemical and biological properties indicate that antibiotic DE-3936 belongs to the group of polyether antibiotics and is identical with lonomycin.
Insights
A novel polyether antibiotic, DE-3936, was discovered from Streptomyces hygroscopicus. This compound shows significant activity against Gram-positive bacteria, mycobacteria, mycoplasma, and protozoa, particularly coccidia.
Area of Science:
- Microbiology
- Natural Product Chemistry
- Pharmacology
Background:
- Streptomycetes are a prolific source of bioactive natural products.
- The discovery of novel antibiotics is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To isolate and characterize a new antibiotic from a Streptomyces strain.
- To determine the chemical properties and biological activity spectrum of the isolated compound.
Main Methods:
- Fermentation of Streptomyces strain No. 9735-1.
- Isolation and purification of antibiotic DE-3936 from the fermentation broth.
- Determination of molecular formula (C44H75O14Na) and chemical properties.
- Antimicrobial and antiprotozoal activity screening.
Main Results:
- Antibiotic DE-3936 was successfully isolated.
- The compound is hydrophobic and identified as a polyether antibiotic.
- DE-3936 exhibited activity against Gram-positive bacteria, mycobacteria, mycoplasma, and protozoa, with notable efficacy against coccidia.
- Chemical and biological properties indicated identity with lonomycin.
Conclusions:
- Antibiotic DE-3936 is a potent polyether antibiotic with a broad spectrum of activity.
- The compound shows promise for therapeutic applications against various microbial and protozoal infections.
- DE-3936 is identical to the known antibiotic lonomycin, confirming its class and potential.